On the other hand, it has been demonstrated that fragments of S-protein, such as truncated S-protein or RBD, have a great potential to be effective vaccine candidates against SARS with no evidence of harmful immune responses [28, 64, 65]. The gene discussed is PROS1; the disease is severe acute respiratory syndrome.